ERBB2 and urinary bladder cancer: Likewise, the ratio of urinary HER2/neu and urinary creatinine was found to be significantly higher in patients with bladder cancer and the authors conclude that a larger cohort is needed to be examined for the use of HER2/neu as a tumor marker [53].